Partial treatment interruptions in HIV-1 patients with multi-drug resistant virus

Trial Profile

Partial treatment interruptions in HIV-1 patients with multi-drug resistant virus

Completed
Phase of Trial: Phase IV

Latest Information Update: 23 Nov 2015

At a glance

  • Drugs Enfuvirtide (Primary)
  • Indications HIV-1 infections
  • Focus Therapeutic Use
  • Most Recent Events

    • 07 Jun 2017 Biomarkers information updated
    • 23 Feb 2009 Additional trial centres added as reported by ClinicalTrials.gov, last updated 23 Feb 2009.
    • 23 Feb 2009 Additional trial investigator Deeks SG reported by ClinicalTrials.gov, last updated 23 Feb 2009.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top